Augusta University shared on LinkedIn:
“Marco Orecchioni, PhD, a researcher with the Immunology Center of Georgia at the Medical College of Georgia at Augusta University, has received The National Institutes of Health Director’s New Innovator Award for his research into how olfactory receptors on immune cells may affect cancer.
The nearly $3.66 million award will support his research over the next five years as his team studies these “immune noses” in melanoma tumors and their potential role in how patients respond to immunotherapy. The research could help identify new targets for future cancer treatments.
Learn more about Dr. Orecchioni’s research and the NIH Director’s New Innovator Award.”
Other posts about Augusta University on OncoDaily.